-
May.292018NEWS
HanAll Biopharma and Daewoong Pharmaceutical Announced the Result of Phase 2 Clinical Trial of HL036(a new drug for dry eye syndrome) in the U.S.
HanAll Biopharma and Daewoong Pharmaceutical Announced the Result of Phase 2 Clinical Trial of HL036..
-
May.242018NEWS
IM156, a new drug with original technology of HanAll Biopharma, is to be Introduced at the American Society of Clinical Oncology
IM156, a new drug with original technology of HanAll Biopharma, is to be Introduced at the American ..
-
Apr.232018NEWS
Seung-kook Park, CEO of HanAll Biopharma Awarded of the President’s Citation on the Science Day
Seung-kook Park, CEO of HanAll Biopharma Awarded of the President’s Citation on the Science Day
-
Apr.232018NEWS
Seung-kook Park, CEO of HanAll Biopharma Awarded of the President’s Citation on the Science Day
Seung-kook Park, CEO of HanAll Biopharma Awarded of the President’s Citation on the Science Day
-
Jan.042018NEWS
HanAll Biopharma Selected as Top 10 Science News of the Year
HanAll Biopharma Selected as Top 10 Science News of the Year
-
Dec.212017NEWS
HanAll Biopharma Awarded the Prime Minister’s Citation at the Korea New Growth Management Awards
HanAll Biopharma Awarded the Prime Minister’s Citation at the Korea New Growth Management Awards